Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:IINN NASDAQ:RCEL NASDAQ:STEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$4.88+3.0%$5.35$4.37▼$11.30$125.78M0.81252,784 shs248,254 shsIINNInspira Technologies OXY B.H.N.$0.88-0.5%$1.55$0.34▼$1.65$31.68M2.16352,435 shs1.95 million shsRCELAvita Medical$4.75+3.0%$4.38$3.22▼$7.12$141.88M1.86309,518 shs128,229 shsSTEXBiosig Technologies$0.74+0.2%$0.99$0.70▼$7.44$133.81M1.941.84 million shs630,026 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx+2.95%+2.31%-16.72%-34.76%-41.49%IINNInspira Technologies OXY B.H.N.0.00%-30.62%-45.27%+83.60%-37.51%RCELAvita Medical+3.04%-7.59%+19.65%+9.70%-17.68%STEXBiosig Technologies+0.24%-4.96%-7.91%-17.47%+73,779,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$4.88+3.0%$5.35$4.37▼$11.30$125.78M0.81252,784 shs248,254 shsIINNInspira Technologies OXY B.H.N.$0.88-0.5%$1.55$0.34▼$1.65$31.68M2.16352,435 shs1.95 million shsRCELAvita Medical$4.75+3.0%$4.38$3.22▼$7.12$141.88M1.86309,518 shs128,229 shsSTEXBiosig Technologies$0.74+0.2%$0.99$0.70▼$7.44$133.81M1.941.84 million shs630,026 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx+2.95%+2.31%-16.72%-34.76%-41.49%IINNInspira Technologies OXY B.H.N.0.00%-30.62%-45.27%+83.60%-37.51%RCELAvita Medical+3.04%-7.59%+19.65%+9.70%-17.68%STEXBiosig Technologies+0.24%-4.96%-7.91%-17.47%+73,779,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.67Moderate Buy$11.50135.66% UpsideIINNInspira Technologies OXY B.H.N. 1.00SellN/AN/ARCELAvita Medical 2.43Hold$7.2552.63% UpsideSTEXBiosig Technologies 2.00Hold$8.00984.30% UpsideCurrent Analyst Ratings BreakdownLatest IINN, RCEL, STEX, and CVRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2026RCELAvita Medical TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/24/2026RCELAvita Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/21/2026STEXBiosig Technologies Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.00 ➝ $8.005/15/2026RCELAvita Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.50 ➝ $6.005/6/2026CVRXCVRx Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/1/2026STEXBiosig Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$56.65M2.29N/AN/A$1.50 per share3.25IINNInspira Technologies OXY B.H.N.$289K109.60N/AN/A$0.06 per share14.69RCELAvita Medical$72.35M2.02N/AN/A($0.55) per share-8.64STEXBiosig Technologies$40K3,353.30N/AN/A$0.83 per share0.89Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$53.31M-$2.02N/AN/AN/A-89.14%-120.76%-48.38%8/6/2026 (Estimated)IINNInspira Technologies OXY B.H.N.-$13.22MN/AN/AN/AN/AN/AN/AN/A8/6/2026 (Estimated)RCELAvita Medical-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)STEXBiosig Technologies-$462.77M-$9.71N/AN/AN/AN/A-717.92%-336.75%N/ALatest IINN, RCEL, STEX, and CVRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026CVRXCVRx-$0.52N/AN/AN/A$15.55 millionN/A8/6/2026N/AIINNInspira Technologies OXY B.H.N.-$0.03N/AN/AN/A$15.00 millionN/A8/6/2026Q2 2026RCELAvita Medical-$0.2928N/AN/AN/A$20.25 millionN/A5/14/2026Q1 2026RCELAvita Medical-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million5/14/2026Q1 2026STEXBiosig TechnologiesN/A-$0.27N/A-$0.27N/AN/A5/11/2026Q1 2026CVRXCVRx-$0.51-$0.50+$0.01-$0.50$14.49 million$14.77 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/ASTEXBiosig TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx2.0110.208.89IINNInspira Technologies OXY B.H.N.0.081.561.30RCELAvita MedicalN/A0.470.38STEXBiosig TechnologiesN/A13.9013.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%IINNInspira Technologies OXY B.H.N.12.72%RCELAvita Medical27.66%STEXBiosig Technologies7.16%Insider OwnershipCompanyInsider OwnershipCVRXCVRx18.90%IINNInspira Technologies OXY B.H.N.29.40%RCELAvita Medical2.24%STEXBiosig Technologies52.73%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.54 million21.52 millionOptionableIINNInspira Technologies OXY B.H.N.2035.95 million25.38 millionNot OptionableRCELAvita Medical13030.78 million30.09 millionOptionableSTEXBiosig Technologies50181.80 million85.94 millionN/AIINN, RCEL, STEX, and CVRX HeadlinesRecent News About These CompaniesStreamex Corp. Details GLDY's Liquidity Infrastructure; ~$12 Million in Seeded Liquidity Supports 24/7, 365 Instant Trading Across Multiple Institutional-Grade VenuesJuly 23, 2026 | globenewswire.comStreamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with WintermuteJuly 23, 2026 | globenewswire.comStreamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance InvestorsJuly 21, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) & Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Head-To-Head ReviewJuly 20, 2026 | americanbankingnews.comInspira Technologies OXY B.H.N. (NASDAQ:QTEX) versus Biosig Technologies (NASDAQ:STEX) Financial ComparisonJuly 20, 2026 | americanbankingnews.comBiosig Technologies (NASDAQ:STEX) Downgraded to "Strong Sell" Rating by Wall Street ZenJuly 18, 2026 | americanbankingnews.comWall Street Zen Downgrades Biosig Technologies (NASDAQ:STEX) to Strong SellJuly 18, 2026 | marketbeat.comStreamex Corp. Announces June 2026 Yield Dividend Distribution for GLDYJuly 17, 2026 | globenewswire.comStreamex GLDY Clears Key Trust Milestone With First Independent Gold Reserve AttestationJuly 8, 2026 | thenewswire.comTStreamex Corp. Announces 10,000,000 Share Repurchase ProgramJuly 7, 2026 | globenewswire.comStreamex Yield-Bearing Gold Asset GLDY Just Went MainstreamJuly 2, 2026 | thenewswire.comTStreamex Corp. Announces First Independent Reserve Attestation by EisnerAmper for GLDYJuly 1, 2026 | globenewswire.comStreamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZEROJune 29, 2026 | globenewswire.comStreamex Corp. Announces May 2026 Yield Dividend Distribution for GLDYJune 22, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) Chairman Morgan Lee Lekstrom Purchases 50,000 SharesJune 16, 2026 | insidertrades.comBiosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 23,810 SharesJune 3, 2026 | insidertrades.com[Video Enhanced] Streamex has Created a Compliant Secondary Market for Real World AssetsJune 2, 2026 | thenewswire.comTInsider Buying: Biosig Technologies (NASDAQ:STEX) Chairman Buys 34,000 Shares of StockMay 29, 2026 | insidertrades.com[Video Enhanced] Streamex Adds Microsoft and PayPal Lead Product Designer to High-Level Talent RosterMay 28, 2026 | thenewswire.comTStreamex Corp. and Orca Announce Launch of 24/7 Decentralized Secondary Liquidity Infrastructure for Tokenized Securities; GLDY the Inaugural AssetMay 27, 2026 | globenewswire.comStreamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and DesignMay 26, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 20263 European Stocks to Carry Investors Through the Back Half of 2026By Chris Markoch | July 1, 2026IINN, RCEL, STEX, and CVRX Company DescriptionsCVRx NASDAQ:CVRX$4.88 +0.14 (+2.95%) Closing price 07/27/2026 04:00 PM EasternExtended Trading$4.88 +0.00 (+0.10%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.Inspira Technologies OXY B.H.N. NASDAQ:IINN$0.88 0.00 (-0.50%) As of 07/24/2026Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Avita Medical NASDAQ:RCEL$4.75 +0.14 (+3.04%) Closing price 07/27/2026 04:00 PM EasternExtended Trading$4.37 -0.38 (-7.98%) As of 04:50 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Biosig Technologies NASDAQ:STEX$0.74 +0.00 (+0.24%) Closing price 07/27/2026 04:00 PM EasternExtended Trading$0.74 0.00 (-0.11%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now AMD’s AI Bubble Could Burst Into Explosive Upside Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? A $1.5 Billion Wake-Up Call for Every AI Company on Wall Street AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight Apple’s Earnings Setup Puts Its Record Rally and AI Patience to the Test Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
